A meta-regression study suggested a linear relationship between HbA1c reduction and MACE risk in patient with arGLP-1.89 Publication on mediation analyses also suggest that cardiovascular benefit could be mediated in part by effects on HbA1c, on blood pressure or reduction in urine albumin-creatinine ratio90,91 (see below), as well as by their effect on lipid profile.81 However, in subgroup analyses of cardiovascular safety studies, baseline HbA1c, weight, previous cardiovascular disease, or renal function did not predict the beneficial effects of these drugs on MACE,87 so other mechanisms, such as the previously mentioned anti-inflammatory, antifibrotic, antiatherogenic, vasodilator, or endothelial function-enhancing effects, have been suggested to influence the cardiovascular benefit of these drugs29,78 (Fig
Thats why doctors start with a low dose and increase it slowly, about every 4 weeks
CMR was performed on a 1.5 T scanner (Siemens, Aera, Erlangen, Germany) with a dedicated cardiac coil
1 Health Canada Warning Summary Potential quality concerns This is one of the central problems with the research chemical market
GST protein elution was conducted with 10 mM reduced GSH in 50 mM Tris pH 8.0 or 250 mM imidazole in 20 mM Tris pH 8.0 (300 mM NaCl)
10.1016/j.exer.2021.108624 25 GuttenplanK